| Income Statement | 2025-09-30 | 2025-06-30 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
| Loss before income taxes | -1,943,376 | -729,536 | -1,525,527 | -1,091,194 |
| Income tax expense | 5,670 | 5,671 | 11,442 | 11,443 |
| Net loss | -1,949,046 | -735,207 | -1,536,969 | -1,102,637 |
| Net loss (income) at subsidiary attributable to noncontrolling interests | -8,282 | 5,533 | 7,112 | -17,025 |
| Net loss attributable to common shareholders | -1,940,764 | -740,740 | -1,544,081 | -1,085,612 |
| Basic (in shares) | 14,958,534 | 14,960,596 | 14,052,754 | 14,118,091 |
| Basic (in usd per share) | -0.13 | -0.05 | -0.11 | -0.08 |
| Diluted (in shares) | 14,958,534 | 14,960,596 | 14,052,754 | 14,118,091 |
| Diluted (in usd per share) | -0.13 | -0.05 | -0.11 | -0.08 |
CUMBERLAND PHARMACEUTICALS INC (CPIX)
CUMBERLAND PHARMACEUTICALS INC (CPIX)